OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Synthesis of Carboxamide‐Containing Tranylcypromine Analogues as LSD1 (KDM1A) Inhibitors Targeting Acute Myeloid Leukemia
María Teresa Borrello, Hanae Benelkebir, Adam F. Lee, et al.
ChemMedChem (2021) Vol. 16, Iss. 8, pp. 1316-1324
Open Access | Times Cited: 7
María Teresa Borrello, Hanae Benelkebir, Adam F. Lee, et al.
ChemMedChem (2021) Vol. 16, Iss. 8, pp. 1316-1324
Open Access | Times Cited: 7
Showing 7 citing articles:
LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials
Beatrice Noce, Elisabetta Di Bello, Rossella Fioravanti, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 76
Beatrice Noce, Elisabetta Di Bello, Rossella Fioravanti, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 76
Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021
Yihui Song, Huiqing Zhang, Xiaoke Yang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 228, pp. 114042-114042
Closed Access | Times Cited: 48
Yihui Song, Huiqing Zhang, Xiaoke Yang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 228, pp. 114042-114042
Closed Access | Times Cited: 48
Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9‐dependent AML
Mélanie Lambert, Samy Jambon, Mohamed Amine Bouhlel, et al.
HemaSphere (2024) Vol. 8, Iss. 5
Open Access | Times Cited: 6
Mélanie Lambert, Samy Jambon, Mohamed Amine Bouhlel, et al.
HemaSphere (2024) Vol. 8, Iss. 5
Open Access | Times Cited: 6
Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present)
Xingrui He, Hang Zhang, Yingqian Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 231, pp. 114143-114143
Closed Access | Times Cited: 19
Xingrui He, Hang Zhang, Yingqian Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 231, pp. 114143-114143
Closed Access | Times Cited: 19
A Quinquennial Review of Potent LSD1 Inhibitors Explored for the Treatment of Different Cancers, with Special Focus on SAR Studies
Khursheed Ahmad Sheikh, Ashif Iqubal, Mohammad Mumtaz Alam, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 2, pp. 152-207
Closed Access | Times Cited: 2
Khursheed Ahmad Sheikh, Ashif Iqubal, Mohammad Mumtaz Alam, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 2, pp. 152-207
Closed Access | Times Cited: 2
Tranylcypromine (TCP)
Yihui Song, Bin Yu
Elsevier eBooks (2023), pp. 257-271
Closed Access | Times Cited: 2
Yihui Song, Bin Yu
Elsevier eBooks (2023), pp. 257-271
Closed Access | Times Cited: 2
Pulrodemstat (CC-90011): a highly potent, selective, and reversible lysine-specific demethylase 1 (LSD1) inhibitor
Yihui Song, Bin Yu
Elsevier eBooks (2024), pp. 467-483
Closed Access
Yihui Song, Bin Yu
Elsevier eBooks (2024), pp. 467-483
Closed Access
